MSB 8.43% $1.35 mesoblast limited

Interesting MSC's Article, page-7

  1. 1,938 Posts.
    lightbulb Created with Sketch. 499
    Why does your tone change when it's a positive for a perceived competitor? Where's the "it's promising but I want to look at the data"? Where's the "it's no systematic review /meta analysis"? How many hours have you spent criticising jadi cell's potency assays?

    Do you not see the hypocrisy?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.